MedPath

Affect of Achillea millefolium in Prophylaxis of oral mucositis

Not Applicable
Conditions
Oral mucositis.
Oral mucositis (ulcerative)
Registration Number
IRCT201309215704N2
Lead Sponsor
Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Iran
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
18
Inclusion Criteria

AML patients including both male or female ones, aged between 16-85 who are candidate for chemotherapy;
Exclusion criteria: Pregnancy; Patients who are not volunteer; Patients with less than 3 weeks duration of hospitalization; Patients with mucositis

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Duration of mucositis. Timepoint: From begining of chemotherapy until 21 days later. Method of measurement: Counting number of days.;Severity of mucositis. Timepoint: First day of chemotherapy until 21 days later. Method of measurement: WHO oral mucositis scale.
Secondary Outcome Measures
NameTimeMethod
Amount of analgesics requested for pain caused by mouth sores. Timepoint: First day of chemotherapy until 21 days later. Method of measurement: Type and dosage of analgesics recorded in patients records in 21 days duration.
© Copyright 2025. All Rights Reserved by MedPath